Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level-Reference-Cited by-同舟云学术

Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level

Published:2018-06-20 Issue:9 Volume:23 Page:818-827
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Lopez-Campos Jose Luis¹²,Carrasco Hernández Laura¹²,Muñoz Xavier²³,Bustamante Víctor⁴,Barreiro Esther²⁵

Affiliation:

1. Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío; Universidad de Sevilla; Sevilla Spain

2. Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III (ISCIII); Madrid Spain

3. Pulmonology Service, Department of Medicine, Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona; Barcelona Spain

4. Servicio de Neumología, Hospital Universitario Basurto, Osakidetza, Departamento de Medicina; EHU-University of the Basque Country; Vizcaya Spain

5. Pulmonology Department-Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, IMIM-Hospital del Mar, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF); Barcelona Biomedical Research Park (PRBB); Barcelona Spain

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13341/fullpdf

Reference107 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary;Vogelmeier;Arch. Bronconeumol.,2017

2. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological treatment of stable phase;Miravitlles;Arch. Bronconeumol.,2017

3. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine - a critical view;Lopez-Campos;COPD,2014

4. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD);Montes de Oca;Arch. Bronconeumol.,2017

5. Major changes in the Spanish COPD guidelines (GesEPOC) 2017: crossing bridges;Lopez-Campos;Arch. Bronconeumol.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease;Frontiers in Immunology;2021-01-08

2. Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders;Advanced Drug Delivery Reviews;2021-01

3. Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease;Pulmonary Therapy;2020-10-16

4. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?;European Respiratory Journal;2020-08-27

5. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies;Advances in Therapy;2020-05-27